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ercutaneous Treatment of
hronic Total Coronary Occlusions
mproves Regional Hyperemic
yocardial Blood Flow and Contractility
nsights From Quantitative Cardiovascular Magnetic Resonance Imaging
drian S. H. Cheng, MBBS, MRCP,* Joseph B. Selvanayagam, FRACP, DPHIL,*
ichael Jerosch-Herold, PHD,† William J. van Gaal, MD,‡ Theodoros D. Karamitsos, MD,*
tefan Neubauer, MD, FRCP,* Adrian P. Banning, MD, FRCP, FESC‡
xford, United Kingdom; and Portland, Oregon
bjectives We sought to investigate temporal changes in contractility and hyperemic and resting
yocardial blood ﬂow (MBF) in dependent and remote myocardium after percutaneous coronary
ntervention (PCI) of chronic total occlusions (CTOs) by using cardiovascular magnetic resonance
CMR) imaging.
ackground Data about the physiological consequences of revascularization of CTOs are limited.
he use of CMR allows investigation of the regional effects of revascularization on MBF and left ven-
ricular contractility.
ethods We prospectively recruited 3 patient groups: 17 patients scheduled for CTO PCI, 17 sched-
led for PCI of a stenosed but nonoccluded coronary artery (non-CTO), and 6 patients with CTO
ho were not scheduled for revascularization. All patients undergoing PCI underwent CMR imaging
24 h before PCI, with repeat CMR imaging 24 h and 6 months after PCI. Each CMR scan consisted
f cine, perfusion, and delayed enhancement imaging. Regional hyperemic and resting MBF, wall
hickening, and transmural extent of infarction were calculated.
esults In both intervention groups, hyperemic MBF in treated segments increased 24 h after PCI
ompared with baseline: CTO group, 2.1  0.2 ml/min/g versus 1.4  0.2 ml/min/g (p  0.01); non-
TO group, 2.5  0.2 ml/min/g versus 1.6  0.2 ml/min/g (p  0.01). This improvement persisted 6
onths after PCI (p  0.01 for both groups). Contractility in treated segments was improved at 24 h
nd 6 months after CTO PCI but only at 6 months after non-CTO PCI. In both intervention groups,
reated segments no longer had reduced MBF or contractility compared with remote segments. In
atients with untreated CTO segments, MBF and wall thickening did not improve at follow-up.
onclusions Successful CTO PCI increases hyperemic MBF as early as 24 h after the procedure, with
greater and earlier improvement in regional contractility than after non-CTO PCI, despite a greater
ikelihood of irreversible injury in CTO segments. (J Am Coll Cardiol Intv 2008;1:44–53) © 2008 by
he American College of Cardiology Foundation
rom the *University of Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford, Oxford, United
ingdom; †Advanced Imaging Research Center, Oregon Health & Science University, Portland, Oregon; and the ‡Department
f Cardiology, John Radcliffe Hospital, Oxford, United Kingdom. Dr. Cheng is funded by a grant from the Oxfordshire Health
ervices Research Committee and Drs. Selvanayagam and Karamitsos are funded by a grant from the British Heart Foundation.anuscript received August 23, 2007; revised manuscript received November 14, 2007, accepted November 21, 2007.
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45hronic total coronary occlusions (CTOs) remain a major
hallenge in percutaneous coronary intervention (PCI).
ew procedural technologies and techniques, including the
etrograde approach, have improved success rates (1) and
eralded increased interest in strategic approaches. Con-
omitantly, the use of drug-eluting stents has reduced
estenosis and reocclusion (2,3) and the need for revascu-
arization (4). Surprisingly, data about the physiological
onsequences of successful opening of a CTO are limited
nd heterogeneous. Studies assessing left ventricular (LV)
unction after balloon angioplasty alone or bare-metal stents
ave used the relatively crude measurements afforded by LV
ngiography and have yielded inconclusive results (5–8). In
hese studies, the benefits of CTO PCI also may have been
imited by the well-documented high rates of restenosis and
eocclusion.
See page 54
Cardiovascular magnetic resonance (CMR) imaging al-
ows serial assessment of regional myocardial function (9),
erfusion (10 –13), and irreversible injury (14 –16), with
igh spatial resolution and reproducibility (17). Using
ome of these techniques, Baks et al. (18) demonstrated
hat successfully opening CTOs resulted in improved
egional contractility 5 months later in myocardial seg-
ents with 25% transmural extent of infarction but re-
ulted in no change in LV ejection fraction. The use of
MR also permits quantitative assessment of absolute
yocardial blood flow (MBF) in ml/min/g (11,19,20).
ffects on regional MBF after PCI have not been previously
tudied in segments subtended by the occluded vessel or in
emote myocardium. In this prospective study, we used
igh-resolution, quantitative CMR before, 24 h, and 6
onths after PCI to investigate changes in myocardial
ontractility and hyperemic and resting MBF in dependent
nd remote myocardium. Changes observed in patients after
TO PCI were compared with changes in patients with
ngina undergoing PCI of nontotally occluded coronaries
nd CTO patients managed medically. We hypothesized
hat hyperemic MBF in the territory subtended by the CTO
ould increase after successful PCI and result in improved
egional wall thickening. Furthermore, we anticipated that
bserved changes in patients undergoing CTO PCI might
e greater in magnitude than those occurring after treat-
ent of nontotally occluded vessels.
ethods
he Oxford Research Ethics Committee approved this
tudy. All participants gave written informed consent.
atient population. A total of 17 consecutive patients with
ngina and/or objective evidence of inducible myocardial
schemia in the relevant territory who were scheduled for pCI of a native coronary CTO were recruited prospectively.
tone et al. (21) defined CTO as lumen compromise
esulting in either Thrombolysis In Myocardial Infarction
TIMI) flow grade 0 or 1, with a likely duration of 3
onths. Two other groups of patients were recruited
rospectively: 17 consecutive patients with angina scheduled
or PCI of a single stenosed but not occluded coronary
rtery and 6 consecutive patients with a documented CTO
ho were managed with medical therapy and were not
cheduled for revascularization. Predetermined exclusion
riteria were the standard contraindications to magnetic
esonance imaging (MRI).
MR imaging time points. All patients undergoing PCI
nderwent an initial CMR scan 24 h before PCI, with
epeat imaging 24 h and 6 months later. Each scan consisted
f cine, perfusion, and delayed enhancement imaging.
atients not scheduled for revascularization were scanned
wice, 6 months apart, using the
ame imaging protocol. A clini-
al review was performed at each
isit.
MR protocol. Patients were
sked to abstain from all com-
etitive adenosine antagonists
or at least 24 h before each
MR scan with a 1.5-T clinical
RI scanner (Siemens Sonata,
rlangen, Germany). Steady-
tate free-precession cine images
repetition time 3.0 ms; echo
ime 1.5 ms; flip angle 60°) were
cquired in long- and short-axis
iews covering the entire LV (22).
After an adenosine infusion
140 g/kg/min) lasting 4 min
less if angina was provoked), a
adolinium-based contrast agent
Gadodiamide, Omniscan, GE Healthcare, Milwaukee,
isconsin) was administered intravenously at a dose of 0.04
mol/kg body weight (injection rate, 6 ml/s), followed by a
aline flush. Perfusion imaging (repetition time 2.2 ms; echo
ime 1.0 ms; flip angle 18°) was performed every cardiac
ycle during first pass, using a T1-weighted fast (spoiled)
radient echo sequence in 3 short-axis imaging planes
epresenting the basal, midventricular, and apical myocar-
ial segments (23). The rest perfusion study was started
15 min after discontinuation of adenosine.
After rest perfusion imaging, a further dose of 0.045
mol/kg gadodiamide was administered, giving a total dose
f 0.125 mmol/kg before delayed enhancement imaging, as
reviously described (24,25).
CI protocol: interventional strategy. All patients were pre-
oaded with aspirin and clopidogrel 24 h before the
Abbreviations
and Acronyms
CMR  cardiovascular
magnetic resonance
CTO  chronic total
coronary occlusion
HE  hyperenhancement
LV  left
ventricle/ventricular
MBF  myocardial blood
flow
MPRI  myocardial
perfusion reserve index
MRI  magnetic resonance
imaging
PCI  percutaneous
coronary intervention
TEI  transmural extent of
infarctionrocedure and received intravenous heparin, either 5,000 U
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46r 70 U/kg at initiation. We performed the CTO proce-
ures by using the antegrade approach. Collaterals were
raded according to the angiographic classification proposed
y Werner et al. (26). Contralateral injection to define the
istal vessel was used when collateral flow was substantial.
redominantly polymer-coated wires were used, including
he Cross-it 150 (Guidant, Boston Scientific, Natick, Mas-
achusetts) and the Shinobi (Cordis, Johnson & Johnson,
iami Lakes, Florida). Stents were deployed at high
ressure (minimum 12 atm). Troponin I was routinely
easured before and 12 h after the procedure in all patients.
atients receiving drug-eluting stents were prescribed aspi-
in indefinitely and clopidogrel for at least 6 months.
MR post-processing. Data were analyzed, blinded to the
atient identity, clinical status, and coronary angiogram. For
egional analysis, all cine, perfusion, and delayed enhance-
ent images were matched with the use of anatomical
andmarks. The LV was divided according to the American
eart Association segmentation model (27), and the coro-
ary angiogram was used to define affected myocardial
egments. Because the most apical segment can be affected
y partial volume effects, it was excluded from the analysis.
e defined “CTO segments” as those myocardial segments
ubtended by the CTO. “Remote segments” were defined as
hose myocardial segments that satisfied all of the following
riteria: not subtended by a coronary stenosis of 50%, not
evascularized, and free of hyperenhancement (HE) on
elayed enhancement imaging.
Global LV function, end-diastolic, end-systolic, and stroke
olume indexes (ml/m2), and ejection fraction (%) were deter-
ined by planimetry of the short-axis cine images. For regional
all thickening assessment, cine MRI was evaluated quantita-
ively with the use of automated computer software (QMass,
ersion 6.2.1, Medis, Medical Imaging Solutions, Leiden, the
etherlands) to determine systolic wall thickening (%) by a
odified centerline method (28). Wall thickening was calcu-
ated by: (end-systolic wall thickness  end-diastolic wall
hickness)/end-diastolic wall thickness  100%.
Quantitative perfusion analysis was performed as previ-
usly described (11). Absolute MBF was determined for
ach myocardial segment in ml/min/g by deconvolution of
ignal intensity curves, with an arterial input function
easured in the LV blood pool (19), taking into account the
elay in the arrival of contrast (20,29). Values for resting
BF were divided by the respective rate-pressure product/
0,000 (30). In the study by Wang et al. (31), hyperemic
BF in adults with no coronary artery calcification was
.31 0.77 ml/min/g (95% confidence interval 1.77 to 4.85
l/min/g). Calculated values for MBF exceeding 5 ml/
in/g were excluded from the analysis.
The amount of delayed HE in the LV was quantified
sing dedicated software (Matlab, version 6.5, MathWorks,
atick, Massachusetts). Hyperenhanced pixels were defined32), and computer-assisted planimetry was used to delin- nate the area of HE (25). Transmural extent of infarction
TEI) in each myocardial segment was calculated by divid-
ng the hyperenhanced area by the total area of that segment
nd scored using a 5-point scoring system: no HE, grade 0; 1%
o 25% HE, grade 1; 26% to 50% HE, grade 2; 51% to 75%
E, grade 3; and 76% to 100% HE, grade 4. Any myocardial
egment with TEI 25% was considered viable (18,32).
tatistical analysis. Statistical analysis was performed with
PSS (version 14.0, SPSS Inc., Chicago, Illinois) and the R
oftware (R: A language and environment for statistical
omputing, R Foundation for Statistical Computing, Vi-
nna, Austria), using the library for linear mixed effects
odels developed by Pinheiro and Bates (33). Deviation
rom normality was tested with the Shapiro-Wilk test.
ontinuous variables are presented as mean  standard
rror of the mean when normally distributed, or median
interquartile range) when not normally distributed. Cate-
orical variables were compared with chi-square statistics.
Linear mixed effects models were used to analyze: 1)
hanges in hyperemic MBF, corrected resting MBF, and
all thickening in follow-up examinations, relative to base-
ine; 2) the differences in these variables at any time point
etween segments subtended by a stenosed coronary artery
nd remote segments; and 3) the differences between patient
roups. The 3 CMR examination times (baseline, 24 h, and
months) and whether myocardial segments were sub-
ended by a stenosed vessel or remote to the stenosis were
ncoded as categorical variables in the fixed effects specifi-
ation, allowing for an interaction between examination time
nd myocardial segment location. The presence and transmu-
ality of HE was graded on the aforementioned 5-point scale,
nd polynomial contrasts for HE grade were used to test
hether MBF and wall thickening changed with HE grade.
The random effects were first modeled as a random
ntercept by subject, with uniform correlation structure for
easurements within each patient. Random intercepts led
o a significantly better fit than models without random
ffects (p  0.0001 for log-likelihood ratio test). To
etermine more complex correlation structures for the
epeated measurements, we considered nested models to fit
he same data and then used a log-likelihood ratio test to
etermine whether added terms in the random effects
pecification fit the data significantly better. Nesting of
xamination time within subjects significantly improved the
t to the data. Relaxing the assumption of compound
ymmetry for the correlation structure to allow for a general
ositive–definite matrix did not improve the fits. Tests were
-sided and significance was accepted at p  0.05.
esults
atient population. Baseline characteristics are shown in
able 1. Participants were predominantly male. There were
o significant differences in clinical risk factor profile or
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47edication prescribed between the 3 patient groups. No
atient had had previous coronary artery bypass surgery.
cross all 3 groups, in 6 of 27 (22%) patients who gave no
istory of previous myocardial infarction, the initial CMR
can detected myocardial HE. At baseline, the odds ratio for
E in a myocardial segment was greatest in medically man-
ged patients (1:6; p 0.1), followed by patients scheduled for
TO PCI (1:21; p  0.01) and lowest in patients scheduled
or non-CTO PCI (1:1,477; p  0.01). The odds of HE in a
yocardial segment were significantly lower in patients sched-
led for non-CTO PCI compared with the CTO PCI group
p  0.05). Patients scheduled for CTO PCI had a greater
roportion of viable segments at baseline compared with
atients with CTO who were medically managed (70 of 85 vs.
1 of 38 respectively; p  0.01).
No patients needed to be excluded because of contrain-
ications to MRI, and all patients completed the CMR
rotocol. However, 16 (13%) of the anticipated 120 stress
erfusion studies were not performed because of asthma (n
Table 1. Baseline Characteristics
CTO PCI
(n  17)
Non-CTO PCI
(n  17)
CTO But
No PCI
(n  6)
Male 14 (82%) 14 (82%) 5 (83%)
Age (yrs) 65  3 63  3 61  8
CCS class at baseline (0/1/2/3/4) 1/2/7/2/5 3/5/8/1/0 2/1/3/0/0
CCS class at 6 months follow-up
(0/1/2/3/4)
5/8/3/1/0 11/2/4/0/0 2/1/1/2/0
Improvement in CCS class at
6-month follow-up
13 (76%) 11 (65%) 1 (17%)
Risk factors for coronary artery
disease
Cigarette smoking 13 (76%) 12 (71%) 5 (83%)
Current smoker 2 (12%) 2 (12%) 2 (33%)
Ex-smoker 11 (65%) 10 (59%) 3 (50%)
Hypertension 9 (53%) 9 (53%) 3 (50%)
Hypercholesterolemia 14 (82%) 16 (94%) 5 (83%)
Diabetes 4 (24%) 3 (18%) 2 (33%)
Family history of heart
disease
5 (29%) 2 (12%) 0 (0%)
Previous history of MI 5 (29%) 4 (24%) 3 (50%)
Pre-existing HE 8 (47%) 5 (29%) 5 (83%)
Medication
Aspirin 17 (100%) 17 (100%) 5 (83%)
Beta-blocker 14 (82%) 10 (59%) 3 (50%)
ACE inhibitor 11 (65%) 13 (76%) 6 (100%)
Statins 16 (94%) 17 (100%) 6 (100%)
Nitrate 8 (47%) 9 (53%) 1 (17%)
Calcium channel blocker 9 (53%) 4 (24%) 3 (50%)
Values are presented as number (%) or mean standard error of the mean.
ACE angiotensin-converting enzyme; CCS Canadian Cardiovascular Society; CTO chronic
total occlusion; HE  hyperenhancement; MI  myocardial infarction; PCI  percutaneous
coronary intervention.8), rest angina (n2), caffeine intake (n 3), and refusalf adenosine at follow-up (n  3). All images were of
ufficient quality for analysis, and no images were excluded.
ngiography and intervention. Visible collaterals (collateral
onnection grade 0 [26]) were present more often in
atients with CTO lesions, compared with those with
on-CTO lesions (74% vs. 0%, p  0.01) (Table 2). The
perator successfully opened the CTO in 15 of 17 (88%)
ases, and all non-CTO lesions were treated successfully.
wo-vessel PCI was performed in 1 patient who was
riginally scheduled for PCI of a single stenosed but not
ccluded coronary artery. Drug-eluting stents were used in
3 of 15 successful CTO cases and 9 of 17 non-CTO PCI
ases. There was no difference in the occurrence of post-
rocedural troponin I elevation (24%) or new myocardial
E (18%) between the 2 intervention groups.
ffect of intervention on morbidity and mortality. A signif-
cantly greater proportion of patients undergoing CTO PCI
ad less angina at 6 months, compared with those managed
edically (76% vs. 17%; p  0.05) (Table 1). No patient in
ny of the groups had suffered death, myocardial infarction, or
nstable angina by follow-up (mean duration after first scan, 17
4 months). One patient who had failed CTO PCI under-
ent coronary bypass surgery a few months after the 6-month
MR scan, and 2 patients with CTO in the medically treated
roup were later referred for revascularization.
ffect of intervention on myocardial blood ﬂow. PATIENTS
NDERGOING CTO PCI. At baseline, resting MBF was
ower in CTO segments compared with remote segments
1.2  0.1 ml/min/g/[mm Hg beats/min/104] vs. 1.3  0.1
l/min/g/[mm Hg beats/min/104]; p  0.05). Similarly,
aseline hyperemic MBF was reduced in CTO segments
ompared with remote segments (1.4  0.2 ml/min/g vs.
.4 0.2 ml/min/g; p 0.01). Both resting and hyperemic
BF in CTO territories decreased significantly with HE
Table 2. Coronary Angiography and Intervention
CTO PCI
(n  17)
Non-CTO PCI
(n  17)
CTO But
No PCI
(n  6)
Total number of tackled lesions 17 18 N/A
Total number of successful
procedures
15 (88%) 17 (100%) N/A
LAD lesion 5 (29%) 12 (67%) 1 (13%)
LCX lesion 4 (24%) 1 (6%) 2 (25%)
RCA lesion 8 (47%) 5 (28%) 5 (63%)
Collateral connection grade
(0/1/2)
6/9/2 n/a 0/4/2
Troponin elevation after PCI 4 (24%) 4 (24%) N/A
New hyperenhancement after
PCI
3 (18%) 3 (18%) N/A
Values are presented as number (%) ormean standard error of themean. Collaterals are graded
according to the angiographic classification proposed by Werner et al. (26).
CTO  chronic total occlusion; LAD  left anterior descending coronary artery; LCX  left
circumflex coronary artery; PCI  percutaneous coronary intervention; RCA  right coronaryartery.
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48rade, with a decrease of 0.6  0.1 ml/min/g/(mm Hg
eats/min/104) for each linear increment in HE grade for
esting MBF (p  0.01) and a decrease of 0.7  0.2
l/min/g for each linear increment in HE grade for
yperemic MBF (p  0.01 for linear trend) (Fig. 1).
Compared with baseline, resting MBF did not change
ignificantly in treated segments after PCI. In contrast, 24 h
fter PCI, hyperemic MBF in treated segments increased
ompared with baseline (2.1  0.2 ml/min/g vs. 1.4  0.2
l/min/g; p  0.01) (Fig. 1). This improvement in hyper-
mic MBF persisted at 6 months after PCI (2.1  0.2
l/min/g vs. 1.4  0.2 ml/min/g; p  0.01) (Fig. 2). These
ncreases in hyperemic MBF at 24 h and 6 months remained
ignificant after simultaneous adjustment of hyperemic
BF by HE grade. After successful CTO PCI, there was
o longer reduced hyperemic or resting MBF in the treated
egments, compared with remote segments, at 24 h and 6
onths after PCI. In remote segments, there was no
ignificant change in either hyperemic or resting MBF at
Figure 1. Changes in MBF in Segments Subtended by a Stenosis and Rem
Each myocardial segment is represented by a circle at each time point, with la
dard error of the mean are displayed for each time point. Hyperemic myocard
occlusion (CTO) (stenosed segments) decreased signiﬁcantly with increasing TE
blood ﬂow (MBF) in all patient groups. In both intervention groups, hyperemic
6 months (6m) after percutaneous coronary intervention (PCI), such that the d
were no longer signiﬁcant. There was no change in hyperemic MBF in untreat
emic MBF than treated CTO segments at 6-month follow-up. *p  0.01 for com
segments at the same time point; ‡p  0.01 for comparison with CTO PCI gro4 h and 6 months after PCI when compared with baseline. rATIENTS UNDERGOING PCI OF NON-CTO LESIONS. At
aseline, resting MBF in the culprit territories was lower
han in remote segments (1.2  0.1 ml/min/g/[mm Hg
eats/min/104] vs. 1.3 0.1 ml/min/g/[mm Hg beats/min/
04]; p  0.01). Hyperemic MBF was also lower in
erritories subtended by a stenosis compared with remote
egments (1.6  0.2 ml/min/g vs. 2.2  0.2 ml/min/g; p 
.01).
Resting MBF did not change significantly in treated
egments after PCI, relative to baseline. In contrast, 24 h
fter PCI, hyperemic MBF in treated segments increased
ompared with baseline (2.5  0.2 ml/min/g vs. 1.6  0.2
l/min/g; p  0.01). As in patients who underwent CTO
CI, this improvement in hyperemic MBF persisted at 6
onths after PCI (2.4  0.2 ml/min/g vs. 1.6  0.2
l/min/g; p  0.01). These increases in hyperemic MBF at
4 h and 6 months remained significant after simultaneous
djustment of hyperemic MBF by HE grade. Both 24 h and
months after PCI, the differences in hyperemic and
gments in the 3 Patient Groups
circles denoting greater transmural extent of infarction (TEI). Mean  stan-
od ﬂow, measured in ml/min/g, in territories subtended by a chronic total
aseline, stenosed segments had signiﬁcantly worse hyperemic myocardial
was greater in treated segments, relative to baseline, at both 24 h (24h) and
ces in hyperemic MBF between treated segments and remote segments
segments or remote segments. Untreated CTO segments had lower hyper-
on with baseline; †p  0.01 for comparison between stenosed and remote
the same time point. MRI  magnetic resonance imaging.ote Se
rger
ial blo
I. At b
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49ents were no longer significant. The improvement in
yperemic MBF in treated segments was not significantly
ifferent between patients undergoing CTO PCI or PCI of
on-CTO lesions. This remained true after adjustment by
aseline hyperemic MBF. As in patients who underwent
TO PCI in remote segments, there was no significant
hange in either hyperemic or resting MBF at 24 h and 6
onths after PCI compared with baseline.
ATIENTS WITH MEDICALLY MANAGED CTO. At baseline,
TO segments had significantly worse resting MBF com-
ared with remote segments (1.2  0.2 ml/min/g/[mm Hg
eats/min/104] vs. 1.4 0.2 ml/min/g/[mm Hg beats/min/
04]; p  0.01). Hyperemic MBF was also lower in CTO
egments compared with remote segments (0.9  0.2
l/min/g vs. 1.6  0.2 ml/min/g; p  0.01). At baseline,
here was no significant difference between hyperemic or
esting MBF in CTO segments in this patient group and
yperemic or resting MBF in segments subtended by a
tenosis to be tackled in the 2 intervention groups.
Resting MBF did not improve in either CTO segments
r remote segments at 6-month follow-up. CTO segments
ontinued to have lower resting MBF than remote segments
t 6-month follow-up (0.8  0.2 ml/min/g/[mm Hg
eats/min/104] vs. 1.0 0.2 ml/min/g/[mm Hg beats/min/
Figure 2. Signal Intensity-Time Curves and Stress Perfusion Images Demon
Shown is a patient with CTO in the middle portion of the right coronary artery
subtended by the CTO, compared with a remote segment in the same slice (to
segment has normalized (bottom left). Representative MRI images on the righ
points, displaying perfusion deﬁcits in the inferoseptal and inferior segments a
which are no longer present 6 months after PCI (bottom). Remote anterosept
intensity; other abbreviations as in Figure 1.04]; p  0.01). eThere was no improvement in hyperemic MBF at
-month follow-up, compared with baseline, in CTO
egments or remote segments (Fig. 3), which remained true
fter simultaneous adjustment of hyperemic MBF by HE
rade. We found that CTO segments continued to have
ower hyperemic MBF than remote segments at 6-month
ollow-up (0.9 0.2 ml/min/g vs. 1.4 0.3 ml/min/g; p
.01). In addition, CTO segments in this patient group had
ignificantly lower hyperemic MBF compared with treated
TO segments in the intervention group (0.9  0.2
l/min/g vs. 2.1  0.2 ml/min/g; p  0.01).
ffect of intervention on regional wall thickening. PATIENTS
NDERGOING CTO PCI. In patients scheduled for CTO
CI, CTO segments had significantly worse wall thick-
ning at baseline compared with remote segments (64 
% vs. 82  6%; p  0.01). This remained true after
imultaneous adjustment of wall thickening by HE grade.
bsolute wall thickening decreased by 38  7% for each
inear increment of HE grade (p  0.01). After successful
TO PCI, compared with baseline, wall thickening in
reated segments improved at 24 h (73  4% vs. 64  5%;
 0.06) and 6 months (77  5% vs. 64  5%; p  0.05)
Fig. 4). These improvements at 24 h and 6 months were
ignificant after simultaneous adjustment of wall thick-
ng Changes in Hyperemic MBF After CTO PCI
line, hyperemic MBF is reduced in the midventricular inferoseptal segment,
t). Six months after PCI, hyperemic MBF in the revascularized inferoseptal
els are peak stress midventricular slices at corresponding imaging time
line (top, borders of the inferoseptal segment delineated by white arrows),
ents are indicated by the black arrow. a.u.  arbitrary units; SI  signalstrati
. Base
p lef
t pan
t base
al segmning by HE grade (p  0.05 and  0.01, respectively).
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50oth 24 h and 6 months after PCI, the differences in wall
hickening between treated segments and remote seg-
ents were no longer significant.
An improvement in absolute wall thickening of 10%
as less likely in segments with greater TEI before PCI (p
0.01 for trend). The absolute improvement in wall
hickening between baseline and 24 h after PCI was 19 
% (p  0.05) for each increment of HE grade at baseline,
ith simultaneous adjustment by wall thickening at base-
ine. Six months after successful CTO PCI, a significantly
reater proportion of viable segments had an absolute
mprovement in wall thickening of 10%, compared with
onviable segments, that is, 46 of 70 (66%) versus 5 of 15
27%); p  0.05.
ATIENTS UNDERGOING PCI OF NON-CTO LESIONS. In pa-
ients scheduled for non-CTO PCI, there was no significant
ifference in wall thickening between territories subtended
y a stenosis and remote segments at any of the 3 exami-
ation time points. In these patients, treated segments had
igher wall thickening only at 6 months, relative to baseline
73  3% vs. 66  4%; p  0.05).
ATIENTS WITH MEDICALLY-MANAGED CTO. At baseline,
TO segments in this patient group had significantly worse
all thickening compared with remote segments (42  7%
Figure 3. Signal Intensity-Time Curves and Stress Perfusion Images Demonstr
A patient with CTO of the middle portion of the right coronary artery. At base
lar inferior segment, subtended by the CTO, compared with a remote segmen
ﬂow in the CTO segment remains unchanged and greatly reduced (bottom le
taken at peak stress at the corresponding imaging time points, displaying perf
remain at 6-month follow-up (bottom). The borders of the inferoseptal segme
the black arrow. Abbreviations as in Figures 1 and 2.s. 68  7%; p  0.01) and CTO segments in those scheduled for PCI (42  7% vs. 64  5%; p  0.05). At
-month follow-up, wall thickening of CTO segments did
ot change relative to baseline, and CTO segments in this
atient group continued to have significantly worse wall
hickening compared with remote segments (35 7% vs. 61
7%; p 0.01) and compared with treated CTO segments
n the intervention group (35 7% vs. 77 5%; p 0.01).
EMOTE SEGMENTS. There was no significant difference in
all thickening of remote segments among all 3 patient
roups at any time point and no significant change in wall
hickening in remote segments at follow-up in any of the
atient groups.
entricular volumes and function. At all imaging time
oints, there were no significant differences in LV end-
iastolic, end-systolic, or stroke volume indexes or ejection
raction between the CTO PCI group and the other 2
atient groups. Ejection fraction was well preserved in all
roups. There was no significant change in LV volume
ndexes or ejection fraction over the 6 months across all 3
atient groups.
iscussion
his study demonstrates that successful PCI of CTO
No Change in Hyperemic MBF in a Medically Managed Patient With a CTO
yperemic MBF, measured in ml/min/g, is greatly reduced in this midventricu-
e same slice (top left). At 6-month follow-up, hyperemic myocardial blood
gnetic resonance imaging on the right panels are midventricular slices
deﬁcits in the inferoseptal and inferior segments at baseline (top), which
delineated by white arrows; the remote anterior segment is indicated byating
line, h
t in th
ft). Ma
usion
nt areignificantly increases hyperemic MBF as early as 24 h after
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51rocedure, an effect that is maintained at 6 months. Fur-
hermore, the magnitude of this improvement in hyperemic
BF is similar to that observed after PCI of nontotally
ccluded arteries. Regional wall contractility in the territory
ubtended by the CTO returns towards normal within the
ame time frame, with no difference between CTO seg-
ents and remote segments at 24 h after PCI. In contrast,
lthough successful PCI of nontotally occluded arteries also
ignificantly increases hyperemic MBF 24 h and 6 months
fter procedure, regional contractility in treated segments
nly improved significantly at 6 months. These clear bene-
ts after CTO PCI might be considered surprising because,
n this study, patients with CTO were more likely to have
rreversibly injured myocardium, compared with patients
ith nontotally occluded arteries, and this may have limited
enefit from PCI.
Recanalization of CTOs can relieve angina and reduce
he 12-month incidence of cardiac death or myocardial
nfarction and the need for coronary artery bypass surgery
34). Similarly, patients in this current study undergoing
Figure 4. Changes in Wall Thickening in Segments Subtended by a Stenos
Each myocardial segment is represented by a circle at each time point, with la
played for each time point. Wall thickening in territories subtended by a CTO
contractility than remote segments. After successful CTO PCI, wall thickening i
thickening by TEI, the differences between treated segments and remote segm
contractility was less likely in segments with greater TEI before PCI. In patients
to baseline. There was no change in wall thickening in untreated CTO segmen
thickening than treated CTO segments at 6-month follow-up. *p  0.01 for co
segments at the same time point; ‡p  0.05 for comparison with CTO PCI groTO PCI had less anginal symptoms at 6 months com- eared with those managed medically. In clinical practice,
ttempting to define which patients with CTO may benefit
rom revascularization is complex and, when the patient has
o symptoms, medical management is the usual strategy
35). In our study, there appear to be almost immediate
hysiological benefits from successful PCI in patients with
TO and angina. For comparison, our study also docu-
ented changes over time in a small number of medically
anaged patients with CTO, as well as patients undergoing
on-CTO PCI. Compared with segments in patients who
ubsequently underwent revascularization, CTO segments
n medically managed patients had significantly lower hy-
eremic and resting MBF and wall thickening at 6-months
ollow-up.
Furthermore, CTO segments in these medically managed
atients demonstrated no improvement in hyperemic or
esting blood flow or wall thickening at 6-month follow-up,
hereas these parameters normalized in the CTO segments
f revascularized patients as early as 24 h after PCI.
edically managed patients were more likely to have
Remote Segments in the 3 Patient Groups
circles denoting greater TEI. Mean  standard error of the mean are dis-
sed signiﬁcantly with increasing TEI. At baseline, CTO segments had worse
ed segments improved, such that, after simultaneous adjustment of wall
were no longer signiﬁcant at 24 and 6 months after PCI. Improvement in
uled for non-CTO PCI, wall thickening improved only at 6 months, relative
emote segments. Untreated CTO segments had signiﬁcantly worse wall
son with baseline; †p  0.01 for comparison between stenosed and remote
the same time point. Abbreviations as in Figure 1.is and
rger
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52aseline, which probably accounts for their relative lack of
nginal symptoms.
Studies using LV angiography to quantify the impact of
uccessful CTO revascularization on LV function have been
nconclusive (5–8). We demonstrated improvement in wall
hickening confined to revascularized CTO segments and
o change in overall ejection fraction after successful CTO
CI, supporting the findings of other recent studies (8,18).
owever, unlike Baks et al. (18), we found no significant
hange in volume indexes after PCI, which may reflect a
ifference in the definition of a CTO occlusion of 6 weeks
n the study by Baks et al. (18) and 3 months in Stone et
l. (21), with consequent disparity between the respective
tudy populations. It might be that there is greater potential
or advantageous ventricular remodeling after successful
reatment of more recent coronary occlusions.
Baks et al. (18) demonstrated that the TEI present before
CI predicted the likelihood of later improvement in
bsolute wall thickening, whereas in patients with a CTO,
uehling et al. (36) found an inverse correlation between
EI and regional wall thickening, as well as both hyperemic
nd resting MBF at baseline. Our study confirmed the
ndings of both studies and, furthermore, is the first to
uantify and relate changes in myocardial thickening, blood
ow, and irreversible injury before and after CTO PCI.
Increased myocardial perfusion reserve index (MPRI)
fter successful PCI has been demonstrated in a heteroge-
eous group of patients (37). In this study, semiquantitative
easurements of the upslope of signal intensity-time curves
ere used to derive MPRI, a ratio of hyperemic to resting
arameters. This approach has fundamental limitations. For
nstance, MPRI could be increased by an elevation in
yperemic MBF, a decrease in resting MBF, or both, which
annot be accurately determined by semiquantitative assess-
ent. Furthermore, small alterations in resting perfusion
ndexes can have a disproportionate effect on MPRI. The
odel-independent deconvolution method used in our
tudy to quantify MBF allowed us to examine the separate
ffects of PCI on hyperemic MBF and resting MBF.
This study shows that the improvement in MPRI after
uccessful PCI is caused solely by significant improvements
n hyperemic MBF, because resting MBF did not change in
ither of the 2 intervention groups. In the CTO PCI cohort,
his presumably reflects the efficacy of collateral circulation.
ailure of this collateral circulation to respond to increased
orkload is the mechanism of angina. We did not detect
erfusion changes at rest or during stress in remote adjoin-
ng segments of myocardium, reflecting the ability of a
ealthy vessel to maintain perfusion to its primarily depen-
ent myocardium.
tudy limitations. This study was observational and nonran-
omized, and there was inevitable bias in selecting which
atients should undergo intervention. The sample size of
he medically managed group was small, despite the fact
1hat all patients eligible for this group were recruited during
he study period.
onclusions
e demonstrate that successful CTO PCI results in a
ignificant, early increase in hyperemic MBF, with a greater
nd earlier improvement in wall thickening than after PCI
f nontotally occluded arteries, despite a greater likelihood
f irreversible injury in CTO segments.
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